Molecular heterogeneity of splenic marginal zone lymphomas: Analysis of mutations in the 5′ non-coding region of the bcl-6 gene

Leukemia

Volumn 15, Issue 4, 2001, Pages 628-634

  Mateo, M S ^a   Mollejo, M ^a   Villuendas, R ^b   Algara, P ^a   Sanchez Beato, M ^b   Martinez P ^a   Piris, M A ^b  

^a HOSPITAL VIRGEN DE LA SALUD   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Bcl 6; Somatic mutation; Splenic marginal zone lymphoma

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; PROTEIN BCL 6;

ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CELL CLONE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; GENE MUTATION; GENETIC HETEROGENEITY; GERMINAL CENTER; HISTOGENESIS; HUMAN; HUMAN TISSUE; HYPOTHESIS; LYMPH FOLLICLE; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTOMA; MOLECULAR BIOLOGY; MORPHOLOGY; MUTATION RATE; NONHODGKIN LYMPHOMA; PHENOTYPE; PRIORITY JOURNAL; SOMATIC MUTATION; SPLENIC MARGINAL ZONE LYMPHOMA; STEM CELL;

EID: 0035074831     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402073     Document Type: Article

References (44)

1. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
2. Splenic marginal zone lymphoma, a distinctive type of low-grade B-cell lymphoma: A clinico-pathological study of 13 cases
3. Splenic marginal zone lymphoma
4. 7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma
5. A marginal zone pattern may be found in different varieties of non-Hodgkin's lymphoma: The morphology and immunohistology of splenic involvement by B cell lymphomas simulating splenic marginal zone lymphoma
6. Normal histology of the human spleen
7. Human Peyer's patches. An immunohistochemical study
8. Human tonsil intraepithelial B cells: A marginal zone related subpopulation
9. The human gut contains a novel population of B lymphocytes which resemble marginal zone cells
10. Splenic marginal zone lymphocytes and related cells in the lymph node: A morphologic and immunohistochemical study
11. Maturation of the immune response in germinal centres
12. k genes with no or little somatic mutation throughout life
13. Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections
14. Analysis of somatic mutation in five B cell subsets of human tonsil
15. Evidence for a large compartment of IgM-expressing memory B cells in humans
16. Analysis of mutations in immunoglobulin heavy chain variable region genes of microdissected marginal zone (MGZ) B cells suggests that the MGZ of human spleen is a reservoir of memory B cells
17. H genes from microdissected human Peyer's patch marginal zone B cells
18. Marginal-zone B cells in the human lymph node and spleen show somatic hypermutations and display clonal expansion
19. Monocytoid B cells are distinct from splenic marginal zone cells and commonly derive from unmutated naive B cells and less frequently from postgerminal centre B cells by polyclonal transformation
20. Clonal selection and learning in the antibody system
21. BCL-6 mutations in normal germinal centre B cells: Evidence of somatic hypermutation acting outside Ig loci
22. Mutations of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes
23. Nonimmunoglobulin gene hypermutation in germinal centre B cells
24. BCL-6 protein is expressed in germinal centre B cells
25. BCL-6 gene product, a 92-to 98-kD nuclear phosphoprotein, is highly expressed in germinal centre B cells and their neoplasic counterparts
26. Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma
27. LAZ3 rearrangements in non-Hodgkin's lymphoma: Correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients
28. Analysis of LAZ3 (BCL-6) status in B cell non-Hodgkin's lymphomas: Results of rearrangement and gene expression studies and a mutational analysis of coding region sequences
29. Frequent somatic hypermutation of the 5′ noncoding region of the BCL6 gene in B-cell lymphoma
30. Frequent mutation of the 5′ noncoding region of the BCL-6 gene in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas
31. Distribution and pattern of BCL-6 mutations throughout the spectrum of B cell neoplasia
32. Mutations analysis of the 5′ noncoding regulatory region of the BCL-6 gene in non-Hodgkin lymphoma: Evidence for recurrent mutations and intraclonal heterogeneity
33. The histopathology of splenic marginal lymphoma with villous lymphocytes
34. Lymph node involvement by splenic marginal zone lymphoma morphological an immunohistochemical features
35. Somatic mutation of bcl-6 genes can occur in the absence of Vh mutations in chronic lymphocytic leukemia
36. Identification of three subgroups of B cell chronic lymphocytic leukemia based upon mutations of BCL-6 and IgV genes
37. H genes provides clinically valuable information in B-cell chronic lymphocytic leukaemia
38. IgV gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukaemia
39. H genes are associated with a more aggressive form of chronic lymphocytic leukaemia
40. Analysis of immunoglobulin genes in splenic marginal zone lymphoma suggests ongoing mutation
41. Somatic mutation analysis of IgH variable regions reveals that tumor cells of most parafollicular (monocytoid) B-cell lymphoma, splenic marginal zone B-cell lymphoma, and some hairy cell leukaemia are composed of memory B lymphocytes
42. Mutation analysis of the rearranged immunoglobulin heavy chain genes of marginal zone cell lymphomas indicates an origin from different marginal zone B lymphocyte subsets
43. Splenic lymphoma with lymphocytes involves B cells with extensively mutated Ig heavy chain variable region genes
44. Mutations of the 5′ non-coding region of the BCL-6 are common in B cell malignancies and can deregulate BCL-6 expression